When you're using WebView2, it uses Windows' built-in browser runtime (Chromium/Edge). Electron ships a browser runtime, but the article notes they're using WebView2.
I was very confused, too. I mean, I do have a YubiKey but Twitter/X has never (or for a very very very long time not) asked me to use my YubiKey to authenticate. As far as I could remember, I only need to use OTP from Authy as 2FA to login. So the whole thing smelled really fishy.
In your link they have only done tests on rabbits.
In this post they have already done some tests on humans and are now increasing the dosage since March.
> Small-scale studies began in 2022. Three groups of four healthy male volunteers aged 20 to 50 received a single intravenous injection of hemoglobin vesicles — artificial oxygen carriers that mimic the structure of red blood cells — in increasing amounts, up to 100 milliliters. While some participants experienced mild side effects, there were no significant changes in vital signs, including blood pressure. Building on that success, Sakai announced that his team was accelerating the process last July. In March, it started administering between 100 and 400 milliliters of the artificial blood cell solution to volunteers.
> If no side effects are confirmed, the trial will shift to examining the treatment’s efficacy and safety. It aims to put the artificial red blood cells into practical use by around 2030.
Because it's two M3 Max chips fused with a high-speed link? The M4 Ultra will presumably be comprised of two M4 Max processors fused similarly (next year).
